Keyphrases
Age of Onset
20%
Clot
20%
Clotting Time
60%
Competing Risk Survival Analysis
20%
Coronavirus Disease (COVID)
100%
COVID-19
20%
D-dimer
20%
Disease Severity
20%
EXTEM
40%
Fibrinogen
40%
Fibrinolysis
20%
FIBTEM
40%
Hemostasis
60%
Hypercoagulability
40%
Hypofibrinolysis
20%
Intensive Care
100%
Intensive Care Unit
20%
Intensive Care Unit Admission
20%
Intensive Care Unit Mortality
40%
Intubation
60%
Linear Mixed Model
20%
Lysis
20%
Lysis Time
20%
Maastricht
100%
Maximum Clot Firmness
20%
Non-survivors
80%
Prothrombin Time
20%
Rotational Thromboelastometry (ROTEM)
100%
Severe Coronavirus Disease 2019
20%
Survivors
60%
Tissue Plasminogen Activator (t-PA)
60%
Viscoelastic Testing
20%
INIS
adjustments
25%
biological markers
100%
comparative evaluations
50%
coronaviruses
50%
dimers
25%
diseases
75%
fibrinogen
50%
fibrinolysis
25%
lysis
50%
mortality
100%
patients
100%
plasminogen
75%
prothrombin
25%
risks
25%
tissues
75%
trajectories
50%
units
100%
Medicine and Dentistry
Biological Marker
100%
Blood Stasis
60%
COVID-19
40%
D-Dimer
20%
Disease Severity
20%
Fibrinogen
40%
Fibrinolysis
20%
Hypercoagulability
40%
Intensive Care
100%
Intensive Care Unit
80%
Intubation
60%
Prothrombin Time
20%
Survival Analysis
20%
Thromboelastometry
100%
Tissue Plasminogen Activator
60%